India · Delayed Price · Currency is INR Eris Lifesciences Statistics
Total Valuation
NSE:ERIS has a market cap or net worth of INR 200.70 billion. The enterprise value is 223.54 billion.
| Market Cap | 200.70B |
| Enterprise Value | 223.54B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
NSE:ERIS has 138.57 million shares outstanding. The number of shares has increased by 0.43% in one year.
| Current Share Class | 138.57M |
| Shares Outstanding | 138.57M |
| Shares Change (YoY) | +0.43% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 59.48% |
| Owned by Institutions (%) | 21.38% |
| Float | 44.19M |
Valuation Ratios
The trailing PE ratio is 32.00 and the forward PE ratio is 30.86. NSE:ERIS's PEG ratio is 1.05.
| PE Ratio | 32.00 |
| Forward PE | 30.86 |
| PS Ratio | 6.44 |
| PB Ratio | 5.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 83.23 |
| P/OCF Ratio | 37.31 |
| PEG Ratio | 1.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.96, with an EV/FCF ratio of 92.71.
| EV / Earnings | 36.08 |
| EV / Sales | 7.18 |
| EV / EBITDA | 19.96 |
| EV / EBIT | 26.59 |
| EV / FCF | 92.71 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.61.
| Current Ratio | 0.74 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 2.11 |
| Debt / FCF | 9.78 |
| Interest Coverage | 4.36 |
Financial Efficiency
Return on equity (ROE) is 18.07% and return on invested capital (ROIC) is 14.01%.
| Return on Equity (ROE) | 18.07% |
| Return on Assets (ROA) | 7.30% |
| Return on Invested Capital (ROIC) | 14.01% |
| Return on Capital Employed (ROCE) | 15.90% |
| Weighted Average Cost of Capital (WACC) | 3.95% |
| Revenue Per Employee | 9.29M |
| Profits Per Employee | 1.85M |
| Employee Count | 3,354 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.06 |
Taxes
| Income Tax | -89.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.64% in the last 52 weeks. The beta is -0.11, so NSE:ERIS's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -18.64% |
| 50-Day Moving Average | 1,377.66 |
| 200-Day Moving Average | 1,483.38 |
| Relative Strength Index (RSI) | 61.76 |
| Average Volume (20 Days) | 72,581 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ERIS had revenue of INR 31.15 billion and earned 6.20 billion in profits. Earnings per share was 45.26.
| Revenue | 31.15B |
| Gross Profit | 23.19B |
| Operating Income | 8.41B |
| Pretax Income | 6.39B |
| Net Income | 6.20B |
| EBITDA | 11.20B |
| EBIT | 8.41B |
| Earnings Per Share (EPS) | 45.26 |
Balance Sheet
The company has 673.00 million in cash and 23.59 billion in debt, with a net cash position of -22.91 billion or -165.36 per share.
| Cash & Cash Equivalents | 673.00M |
| Total Debt | 23.59B |
| Net Cash | -22.91B |
| Net Cash Per Share | -165.36 |
| Equity (Book Value) | 38.96B |
| Book Value Per Share | 285.48 |
| Working Capital | -5.37B |
Cash Flow
In the last 12 months, operating cash flow was 5.38 billion and capital expenditures -2.97 billion, giving a free cash flow of 2.41 billion.
| Operating Cash Flow | 5.38B |
| Capital Expenditures | -2.97B |
| Depreciation & Amortization | 2.80B |
| Net Borrowing | -1.25B |
| Free Cash Flow | 2.41B |
| FCF Per Share | 17.40 |
Margins
Gross margin is 74.46%, with operating and profit margins of 26.99% and 19.89%.
| Gross Margin | 74.46% |
| Operating Margin | 26.99% |
| Pretax Margin | 20.50% |
| Profit Margin | 19.89% |
| EBITDA Margin | 35.96% |
| EBIT Margin | 26.99% |
| FCF Margin | 7.74% |
Dividends & Yields
This stock pays an annual dividend of 7.21, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 7.21 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.43% |
| Shareholder Yield | 0.07% |
| Earnings Yield | 3.09% |
| FCF Yield | 1.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:ERIS is 1,696.60, which is 17.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,696.60 |
| Price Target Difference | 17.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 14.56% |
| EPS Growth Forecast (3Y) | 17.12% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |